Growing Physician-Recommended Patented Pediatric Supplement Brand | Amazon and 45K Pharmacies | 29K Subscribers | $4M+ SDE
Investigate. Strong cash flow (29% margin, $4.1M SDE) and diversified channels (Amazon + 45K pharmacies + subscription base) offset high entry valuation (5.54x SDE) and Amazon concentration risk typical of FBA sellers.
- •5.54x SDE multiple is above preferred <4x threshold for search-fund acquisition
- •Likely high Amazon revenue concentration (common in FBA listings); pharmacy/subscription mix not quantified
- •No growth rate or MRR trend data provided; profitability sustainability unclear
- •Patented product may have IP transfer/licensing complexity and regulatory dependency
- •Diversified distribution: Amazon, 45K+ pharmacies, 29K subscribers (recurring revenue component)
This listing is a physician-recommended pediatric supplement brand with patent protection, distributed across Amazon, approximately 45,000 pharmacy locations, and a 29,000-subscriber direct subscription model.
Financial snapshot: Annual revenue of $14.2M with $4.1M seller's discretionary earnings (29.3% profit margin). Monthly revenue averages $1.18M. The asking price is $23M, representing a 5.54x SDE multiple.
This business suits operators with healthcare/wellness background, existing pharmacy relationships, or Amazon FBA expertise who can validate channel contribution margins and subscription churn. Evaluate exposure to Amazon policy changes, pharmacy contract renewal terms, and the transferability of the patent and physician relationships.
Before proceeding, request channel-level P&L (Amazon vs. pharmacy vs. direct subscription), 3-year revenue trend, customer acquisition cost by channel, and churn metrics for the subscriber base. Assess regulatory and compliance burden tied to pediatric supplements.
Ready to make a move?
LamboApp surfaces the deal. The broker holds the intake. Do your own diligence — our fit score is a starting point, not a green light.